Skip to main content
OpenTrials

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

948 public trials 78 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.

NCT00708370

Conditions
Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Pfizer Investigational Site Jitra, Kubang Pasu, Kedah, Malaysia
  • Pfizer Investigational Site Kulim, Kedah, Malaysia
  • Pfizer Investigational Site Sik, Kedah, Malaysia
  • Pfizer Investigational Site Kubang Kerian, Kelantan, Malaysia
View all 22 locations
View Trial Details
Completed

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

NCT00442325

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
Locations
  • Pfizer Investigational Site Ioannina, Greece
  • Pfizer Investigational Site Kallithea, Athens, Greece
  • Pfizer Investigational Site Pireaus, Greece
  • Pfizer Investigational Site Thessaloniki, Greece
View all 32 locations
View Trial Details
Completed

A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

NCT00645151

Conditions
Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
Locations
  • Pfizer Investigational Site Belo Horizonte, Minas Gerais, Brazil
  • Pfizer Investigational Site Curitiba, Paraná, Brazil
  • Pfizer Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
  • Pfizer Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
View all 33 locations
View Trial Details
Completed

A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

NCT00644670

Conditions
Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
Locations
  • Pfizer Investigational Site Antwerp, Belgium
  • Pfizer Investigational Site Brasschaat, Belgium
  • Pfizer Investigational Site Brussels, Belgium
  • Pfizer Investigational Site Edegem, Belgium
View all 17 locations
View Trial Details
Completed

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

NCT00442845

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
Locations
  • Pfizer Investigational Site Mississauga, Ontario, Cameroon
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Medicine Hat, Alberta, Canada
View all 121 locations
View Trial Details
Completed

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

NCT00412113

Conditions
Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Mesa, Arizona, United States
View all 51 locations
View Trial Details

Related conditions